Condition: Hydrocephalus · Sponsor: Sophysa
The SAPPHYRE study is an ambispective (retrospective and prospective) PMCF study with the objective to evaluate the safety and performance of the Polaris® 24 adjustable valve system in the treatment of 126 patients with hydrocephalus.
This description comes directly from the study's public registry record.
Océane Amiotte, Engineering Degree · +33 381885382 · oamiotte@sophysa.fr
Huong Tra LE, Msc · +33 1 69 35 3500 · tle@sophysa.com
Always discuss trial participation with your own doctor first.
| La Timone Children's Hospital | Marseille, France | Recruiting |
| La Pitié Salpétrière Hospital | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04746625